Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta
Nasdaq also announced today that it will delist the common stock of Statera Biopharma, Inc. Statera Biopharma, Inc. common stock was suspended on January 12, 2023, and has not traded on Nasdaq since that time.NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on November 30, 2022, and have not traded on Nasdaq since that time.
纽约，2023年3月1日（GLOBE NEWSWIRE）——纳斯达克股票市场今天宣布，它将把EQONEX LIMITED的普通股退市。EQONEX LIMITED普通股于2022年11月30日暂停，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock of Scopus BioPharma Inc. Scopus BioPharma Inc. common stock was suspended on December 19, 2022, and has not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Scopus BioPharma Inc的普通股退市。Scopus BioPharma Inc.普通股已于2022年12月19日停牌，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock and warrant of Peak Bio, Inc. Peak Bio, Inc.'s securities were suspended on January 10, 2023, and have not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Peak Bio, Inc.的普通股和认股权证退市 Peak Bio, Inc.s 的证券于 2023 年 1 月 10 日暂停，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock of Statera Biopharma, Inc. Statera Biopharma, Inc. common stock was suspended on January 12, 2023, and has not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Statera Biopharma, Inc.的普通股退市。Statera Biopharma, Inc.普通股于2023年1月12日停牌，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock of Tricida, Inc. Tricida, Inc. common stock was suspended on January 24, 2023, and has not traded on Nasdaq since that time.
纳斯达克今天还宣布将把Tricida, Inc.的普通股退市。Tricida, Inc.普通股已于2023年1月24日停牌，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the Class A Common Stock, units, and warrants of Arbor Rapha Capital Bioholdings Corp. I. Arbor Rapha Capital Bioholdings Corp. I's securities were suspended on January 24, 2023, and have not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Arbor Rapha Capital Bioholdings公司的A类普通股、单位和认股权证退市。Arbor Rapha Capital Bioholdings Corp. I的证券已于2023年1月24日暂停，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock of Calithera Biosciences, Inc. Calithera Biosciences, Inc.'s common stock was suspended on February 2, 2023, and has not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Calithera Biosciences, Inc.的普通股退市 Calithera Biosciences, Inc.的普通股于 2023 年 2 月 2 日停牌，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock of Waitr Holdings Inc. Waitr Holdings Inc.'s common stock was suspended on February 2, 2023, and has not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Waitr Holdings Inc.的普通股退市。”的普通股于 2023 年 2 月 2 日停牌，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock of Allied Healthcare Products, Inc. Allied Healthcare Products, Inc.'s common stock was suspended on February 3, 2023, and has not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Allied Healthcare Products, Inc.的普通股退市。”的普通股于 2023 年 2 月 3 日停牌，此后一直没有在纳斯达克上市。
Nasdaq also announced today that it will delist the common stock of Metacrine, Inc. Metacrine, Inc.'s common stock was suspended on February 9, 2023, and has not traded on Nasdaq since that time.
纳斯达克今天还宣布，它将把Metacrine, Inc.的普通股退市。”的普通股于2023年2月9日停牌，此后一直没有在纳斯达克上市。
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies' securities are trading on another venue, please review the companies' public filings or contact the company directly.
纳斯达克将向美国证券交易委员会提交一份25号表格以完成退市。除牌在提交25号表格十天后生效。有关这些公司的新闻和其他信息，包括退市的依据以及两家公司的证券是否在其他场所交易，请查看公司的公开文件或直接与公司联系。
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.
有关纳斯达克股票市场的更多信息，请访问纳斯达克网站，纳斯达克的证券退市规则见纳斯达克规则5800系列，可在纳斯达克网站上查阅：https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series。
-NDAQO-
-NDAQO-
